Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 510Genitourinary 289Other hematologic neoplasm 163Plasma cell 67Myeloid 19Sarcoma 17Dermatologic 16Thoracic 10Tumor-Agnostic 8Breast 7Gynecologic 6Gastrointestinal 6CNS 6Other solid neoplasm 2Classical hematology 2Other neoplasm 1Head & Neck 1Endocrine 1

Conditions

Oropharyngeal Neoplasms 1Cranial Nerve Diseases 1

Interventions

Cisplatin 630Radiotherapy 339pembrolizumab 329Cetuximab 283Docetaxel 225Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 76toripalimab 74Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 48Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 43130-nm albumin-bound paclitaxel 43tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prednisone × Head & Neck × Clear all
NCT04151082 2026-01-13

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
35 enrolled
Head & Neck

Cranial Nerve Diseases, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡